SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Strong Long6/30/2015 7:52:17 PM
1 Recommendation

Recommended By
mokelumne river

  Read Replies (1) of 2026
 
I've run across several articles this past month published in French magazines about Vitaros. At least 2 of them said something similar about Vitaros that I was not aware of. I was under the impression that the reason that Vitaros was not to be used more than once per day or 3 times per week, was a limitation based on the potential for skin irritation at the application site. According to the articles, the reason for the limitation is the increased risk of priapism, citing that Alprostadil is a very potent vasodilator.

Can we get some good news please? :)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News